What Is NAD+?

NAD+ sits apart from most of this knowledge centre, which is concerned with peptides. It is a coenzyme, a small organic molecule of an entirely different chemical class, and getting that classification right is the first thing a profile should do. This page treats NAD+ as a research compound and keeps to its chemistry and its laboratory context, leaving aside the cellular roles it is associated with elsewhere.

The difference between NAD+ and the peptides around it in this knowledge centre is not a detail but a change of chemical category. A peptide is a chain of amino acids linked by peptide bonds; NAD+ is a dinucleotide, built from nucleotide units and phosphate groups. The two classes are made of different building blocks, described by different conventions, and behave differently, so the habits formed around peptides do not all transfer.

Recognising the category has practical force. It explains why some peptide-specific framing is set aside for NAD+, why its handling emphasises oxidation and moisture, and why its chemistry is discussed in terms of a redox pair rather than a sequence. A reader who keeps the classification in view will approach the molecule on the right terms from the outset.

The full name, nicotinamide adenine dinucleotide, is a structural description. NAD+ is a dinucleotide: two nucleotide units, one carrying a nicotinamide group and one an adenine, linked through a pair of phosphate groups. That architecture is quite distinct from a peptide chain of amino acids, and it is why the molecule belongs to nucleotide chemistry rather than peptide chemistry.

A defining feature of the molecule is that it exists as a redox pair. The oxidised form is written NAD+, and a reduced form, NADH, differs by the addition of electrons and a hydrogen. This capacity to switch between forms is a matter of the molecule’s chemistry, and it is also why handling deserves attention, since the oxidation state can change under the wrong conditions, a theme our note on oxidation and research material stability develops.

The existence of a reduced counterpart is worth dwelling on, because it is what marks NAD+ as chemically active in a way a stable peptide is not. The oxidised and reduced forms are two states of the same molecular framework, and the ease with which a system can move between them is precisely what makes the compound useful in biochemistry and what makes it demanding to keep. A material that can change form is one whose identity has to be actively maintained, not merely confirmed once.

As a research material NAD+ is supplied as a powder, listed as NAD+ in the catalogue, and handled with the care its chemistry calls for. Because it is not a peptide, some peptide-specific framing does not apply, but the general principles for research compounds, covered in understanding research compounds, do.

NAD+ is widely discussed in popular sources in connection with claims this resource does not make. Those concern outcomes and lie outside a research-use-only account; the molecule is presented here strictly as a coenzyme studied in the laboratory. That boundary keeps the profile factual.

How NAD+ is approached as a research subject is taken up in the NAD+ research overview, and the oxidation, light and moisture considerations its chemistry raises are the subject of the NAD+ storage & handling guide. The wider range is in the research catalogue.

All products are supplied strictly for laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or food. Not for diagnostic or therapeutic use. The material on this page is educational and factual: it summarises areas of published scientific investigation and general laboratory practice. It is not guidance for the use of any material in humans or animals, and nothing here should be read as a claim about safety, performance, or outcomes. Where a specific product specification or safety data sheet is provided with a material, that document is the definitive reference and takes precedence over any general information given here.